Calm Sleep Coaching
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04566822 |
|
Recruitment Status :
Completed
First Posted : September 28, 2020
Last Update Posted : December 24, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
The Centers for Disease Control and Prevention has identified insufficient sleep as a public health epidemic, with more than 70 million US adults experiencing insomnia each year. However, access to current evidence-based interventions for sleep disturbance (e.g., Cognitive Behavior Therapy for Insomnia [CBT-I]) is limited due to the need for specialized providers as well as monetary and logistical barriers that prevent many individuals from attending in-person treatment sessions (e.g., scheduling, transportation, childcare). Novel modes of delivery are needed to extend the benefits of these treatments to a wider range of individuals in need.
The purpose of this study is to evaluate Calm Sleep Coaching in adults with sleep disturbance (score of greater than or equal to 8 on the Insomnia Severity Index) by 1) determining the feasibility (i.e., acceptability, demand) of Calm Sleep Coaching and 2) determining the preliminary effects of Calm Sleep Coaching on primary (sleep quality) and secondary outcomes (i.e., symptoms of insomnia, mental health, well-being, resilience, and productivity). Investigators also aim to explore coaches' experiences with implementation of Calm Sleep Coaching using an investigator developed survey and assess the participants stage of change (transtheoretical model) throughout the program. Investigators hypothesize that 1) Calm Sleep Coaching will be feasible among individuals with sleep disturbance and 2) participating in the Calm Sleep Coaching program is associated with improvements in primary and secondary outcomes compared to the control group (with greater improvements observed among those participating in higher touch coaching interventions).
Investigators aim to recruit N=200 participants. Participants will be randomized into one of four groups: 1) High-touch intervention (N=50; real-time video and chat messaging, coach response via live videos), 2) medium-touch intervention (N=50; real-time video and pre-recorded video and chat messaging with response from coach), 3) low-touch intervention (N=50; chat messaging with response from coach), or 4) Sleep education control (N=50; no coaching).
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Sleep Disturbance | Behavioral: High Touch intervention Behavioral: Medium Touch intervention Behavioral: Low Touch intervention Behavioral: Sleep Education Control | Not Applicable |
Show detailed description
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 388 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Intervention Model Description: | The participants will be blinded as to which group is receiving the intervention being assessed |
| Masking: | Single (Participant) |
| Primary Purpose: | Supportive Care |
| Official Title: | Testing the Feasibility and Preliminary Effects of a Six-week Online Program, "Calm Sleep Coaching", in Adults With Sleep Disturbance |
| Actual Study Start Date : | September 21, 2020 |
| Actual Primary Completion Date : | December 22, 2020 |
| Actual Study Completion Date : | December 22, 2020 |
| Arm | Intervention/treatment |
|---|---|
Experimental: High-touch intervention
|
Behavioral: High Touch intervention
The Calm app is downloadable by participants onto their smartphone to access the Calm app and Calm Sleep Coaching. The Calm app is used to deliver the intervention to experimental group participants. |
Experimental: medium-touch intervention
|
Behavioral: Medium Touch intervention
The Calm app is downloadable by participants onto their smartphone to access the Calm app and Calm Sleep Coaching. The Calm app is used to deliver the intervention to experimental group participants. |
Experimental: low-touch intervention
|
Behavioral: Low Touch intervention
The Calm app is downloadable by participants onto their smartphone to access the Calm app and Calm Sleep Coaching. The Calm app is used to deliver the intervention to experimental group participants. |
Sham Comparator: Sleep education control
|
Behavioral: Sleep Education Control
Participants in the sleep education control will not have access to a coach. Weekly sleep education will be accessible to the participant on a weekly basis. The sleep education content will be the same that is provided to the intervention participants. |
- Sleep Disturbance [ Time Frame: Change from baseline to post-intervention (week 6) ]Sleep Disturbance will be measured with the Insomnia Severity Index. Scores range from 0-28 with higher score indicates more severe insomnia.
- Sleep Quality: Pittsburgh Sleep Diaries [ Time Frame: Change from baseline to post-intervention (week 6) ]Sleep Quality will be measured using the Pittsburgh Sleep Diaries. Scores range from 0-8 with higher scores indicating greater sleep quality.
- Stress [ Time Frame: Change from baseline to post-intervention (week 6) ]Stress will be measured using the Perceived Stress Scale. Scores on the PSS-10 range from 0-40 with greater scores indicating greater stress.
- Depression [ Time Frame: Change from baseline to post-intervention (week 6) ]Depression will be measured using the Patient Health Questionnaire Depression Scale-8. Score on the PHQ-8 range from 0-24 with higher scores indicating greater depressive symptoms.
- Anxiety [ Time Frame: Change from baseline to post-intervention (week 6) ]Anxiety will be measured using the General Anxiety Disorder-7. Scores on the GAD-7 range from 0-21 with higher scores indicating greater anxiety.
- Well-being [ Time Frame: Change from baseline to post-intervention (week 6) ]Well-being will be measured using the World Health Organization-Five Well-Being Index. Scores on the WHO-5 range from 0-25 with higher scores indicating greater sense of well-being.
- Resilience [ Time Frame: Change from baseline to post-intervention (week 6) ]Resilience will be measured using the Connor-Davis Brief Resilience Scale. Scores on the CD-RISC-10 range from 0-40 with higher scores indicating greater resilience.
- Productivity [ Time Frame: Change from baseline to post-intervention (week 6) ]Productivity will be measured using the Work Productivity and Activity Impairment Questionnaire. Scores on the WPAI:GH are provided as a percentage with higher numbers indicating greater impairment and less productivity.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- At least 18 years of age
- Own a smartphone
- Reside in the US or a US territory
- Only English speakers
- Score of greater than or equal to 8 on the Insomnia Severity Index
- Willing to download the Calm app to their smartphone
- Willing to be randomized
Exclusion Criteria:
• Greater than or equal to 60 minutes/month of meditation for the past six months
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04566822
| United States, Arizona | |
| Arizona State University | |
| Phoenix, Arizona, United States, 85004 | |
| Principal Investigator: | Jennifer Huberty, PhD | Arizona State University |
| Responsible Party: | Arizona State University |
| ClinicalTrials.gov Identifier: | NCT04566822 |
| Other Study ID Numbers: |
STUDY00012385 |
| First Posted: | September 28, 2020 Key Record Dates |
| Last Update Posted: | December 24, 2020 |
| Last Verified: | December 2020 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Dyssomnias Parasomnias Sleep Wake Disorders Nervous System Diseases Mental Disorders |

